Coordinated In Vitro Release of Granulysin, Perforin and IFN-Î³ in TB and HIV/TB Co-Infection Associated with Clinical Outcomes before and after Anti-TB Treatment.

Pitabut, Nada; Dhepakson, Panadda; Sakurada, Shinsaku; Keicho, Naoto; Khusmith, Srisin

Pitabut, Nada; Dhepakson, Panadda; Sakurada, Shinsaku; Keicho, Naoto; Khusmith, Srisin.

Afiliación

Pitabut N; Faculty of Medicine, King Mongkut's Institute of Technology Ladkrabang, Bangkok 10520, Thailand.
Dhepakson P; Medical Biotechnology Center, Medical Life Sciences Institute, Department of Medical Sciences, Ministry of Public Health, Nonthaburi 11000, Thailand.
Sakurada S; Bureau of International Medical Cooperation, National Center for Global Health and Medicine, Tokyo 162-8655, Japan.
Keicho N; Department of Pathophysiology and Host Defense, The Research Institute of Tuberculosis-Japan Anti-Tuberculosis Association, Tokyo 204-8533, Japan.
Khusmith S; Department of Microbiology and Immunology, Faculty of Tropical Medicine, Mahidol University, Bangkok 10400, Thailand.

Pathogens ; 9(8)2020 Aug 14.

Article en En | MEDLINE | ID: mdl-32823923

Palabras clave

H37Ra; IFN-Î³; PPD; anti-TB treatment; granulysin; granzyme-B; in vitro; perforin

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Pathogens Año: 2020 Tipo del documento: Article País de afiliación: Tailandia Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google